5-hydroxymethyl tolterodine 5mg 5mg | Purity Not Available
Adooq Bioscience
5-hydroxymethyl tolterodine is a metabolite of Tolterodine, a muscarinic receptor antagonist used in the treatment of urinary incontinence.
More Information Supplier PageSearch Results
5-hydroxymethyl tolterodine 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
5-hydroxymethyl tolterodine is a metabolite of Tolterodine, a muscarinic receptor antagonist used in the treatment of urinary incontinence.
More Information Supplier Page5-hydroxymethyl tolterodine 100mg 100mg | Purity Not Available
Adooq Bioscience
5-hydroxymethyl tolterodine is a metabolite of Tolterodine, a muscarinic receptor antagonist used in the treatment of urinary incontinence.
More Information Supplier Page5-hydroxymethyl tolterodine 10mg 10mg | Purity Not Available
Adooq Bioscience
5-hydroxymethyl tolterodine is a metabolite of Tolterodine, a muscarinic receptor antagonist used in the treatment of urinary incontinence.
More Information Supplier PageRS-127445 50mg 50mg | Purity Not Available
Adooq Bioscience
RS-127445 is a potent and selective antagonist at the serotonin 5-HT2B receptor, with around 1000x selectivity over the closely related 5-HT2A and 5-HT2C receptors.
More Information Supplier PageRS-127445 5mg 5mg | Purity Not Available
Adooq Bioscience
RS-127445 is a potent and selective antagonist at the serotonin 5-HT2B receptor, with around 1000x selectivity over the closely related 5-HT2A and 5-HT2C receptors.
More Information Supplier PageRS-127445 100mg 100mg | Purity Not Available
Adooq Bioscience
RS-127445 is a potent and selective antagonist at the serotonin 5-HT2B receptor, with around 1000x selectivity over the closely related 5-HT2A and 5-HT2C receptors.
More Information Supplier PageSL 0101-1 10mg 10mg | Purity Not Available
Adooq Bioscience
SL 0101-1 is a selective inhibitor of p90 ribosomal S6 kinase (RSK) (IC50 = 89 nM for RSK2). It also inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.
More Information Supplier PageBGJ398 (NVP-BGJ398) 50mg 50mg | Purity Not Available
Adooq Bioscience
BGJ398 is a potent and selective inhibitor with potential antiangiogenic and antineoplastic activities of fibroblast growth factor receptor (FGFR) tyrosine kinases 1, 2, 3 and 4 (with IC50 values of 0.9, 1.4, 1.0 and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4 respectively).
More Information Supplier PageBGJ398 (NVP-BGJ398) 5mg 5mg | Purity Not Available
Adooq Bioscience
BGJ398 is a potent and selective inhibitor with potential antiangiogenic and antineoplastic activities of fibroblast growth factor receptor (FGFR) tyrosine kinases 1, 2, 3 and 4 (with IC50 values of 0.9, 1.4, 1.0 and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4 respectively).
More Information Supplier Page